Venture capital firm Aditum Bio is going all-out for a new collaboration with Fosun Pharma, launching a subsidiary with the ...
After Generation Bio telegraphed plans to lay off 90% of its staff this summer, Xoma Royalty has come knocking to bring yet ...
Amphix Bio's latest funding round brings total raised to $18 million as company prepares for clinical trials. Learn more here ...
Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBGM01, a functional GLB1 gene encoding ß-galactosidase for infantile GM1; ...
Entera Bio (ENTX) congratulates the FNIH-ASBMR-SABRE team following the Food and Drug Administration broad qualification of total hip bone mineral ...
Onego Bio claims that The EVERY Co's "threats" have negatively impacted its ability to "secure investment and finalize ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback